Back
Royalty Pharma PLC Vs. CEL-SCI Industry Stock Comparison
Sell
27
RPRX
Royalty Pharma PLC
Last Price:
27.38
Seasonality Move:
5.43%
Sell
43
CVM
CEL-SCI
Last Price:
0.92
Seasonality Move:
6.48%
Sell
27
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
- The current Royalty Pharma PLC [RPRX] share price is $27.37. The Score for RPRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CEL-SCI (CVM)
is a Sell
Is CEL-SCI a Buy, Sell or Hold?
- The current CEL-SCI [CVM] share price is $0.92. The Score for CVM is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- CVM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $27.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing selling pressure, which indicates risk of future bearish movement.
CVM Stock Price Chart
RPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 41.16 | Sell |
| Chaikin Money Flow: | -1671278 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.57 - 28.17) | Sell |
| Bollinger Bands (100): | (26.68 - 28.42) | Sell |
CVM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 34.51 | Sell |
| Chaikin Money Flow: | -141888 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.97 - 1.11) | Sell |
| Bollinger Bands (100): | (1.06 - 1.28) | Sell |
RPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.81 | Sell |
| 20-day SMA: | 27.86 | Sell |
| 50-day SMA: | 27.94 | Sell |
| 200-day SMA: | 28.25 | Sell |
| 8-day EMA: | 27.76 | Sell |
| 20-day EMA: | 27.84 | Sell |
| 50-day EMA: | 27.86 | Sell |
| 200-day EMA: | 28.32 | Sell |
CVM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.96 | Sell |
| 20-day SMA: | 1.03 | Sell |
| 50-day SMA: | 1.09 | Sell |
| 200-day SMA: | 1.58 | Sell |
| 8-day EMA: | 0.96 | Sell |
| 20-day EMA: | 1.01 | Sell |
| 50-day EMA: | 1.09 | Sell |
| 200-day EMA: | 1.46 | Sell |
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and an increase next year of $0.40 per share.
CEL-SCI Earnings Growth & CVM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.18 per share.
Royalty Pharma PLC Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CEL-SCI Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||